Nexstim announces navigated brain therapy system, the first personalized magnetic stimulation solution with CE mark for treatment of depression and stroke rehabilitation

Helsinki, Finland: 10 December 2012 - Nexstim Oy, a medical device company, announced today that the Navigated Brain Therapy (NBT) System meets the requirements of the European Medical Devices Directive (MDD).The NBT System is the first non-invasive, non-systemic therapeutic device CE-marked to offer patients a personalized treatment for major depression. In addition, the NBT System is CE-marked for use in patients recovering from stroke as a supplement to conventional rehabilitation. The navigation feature of NBT allows for accurately targeting therapy directly to the cortical structures believed to be involved in brain dysfunctions.

More info on the press release or on Nexstim's website.

Next > Capricorn ICT Arkiv launched !

Previous > FRX Polymers Selected by AlwaysOn as a GoingGreen Silicon Valley Global 200 Winner